Table 1.
Summary of the characteristics of the 27 trials.
| Characteristics | Value | |
| Year of publication, n (%) |
|
|
|
|
2007-2009 | 2 (7) |
|
|
2010-2012 | 4 (15) |
|
|
2013-2015 | 10 (37) |
|
|
2016-2019 | 11 (41) |
| Study location, n (%) |
|
|
|
|
North America | 13 (48) |
|
|
Europe | 7 (26) |
|
|
Asia | 5 (19) |
|
|
Africa | 2 (7) |
| Disease studied, n (%) |
|
|
|
|
Type 2 diabetes | 19 (70) |
|
|
Hypertension | 6 (22) |
|
|
Type 2 diabetes and/or hypertension | 1 (4) |
|
|
Coexisting type 2 diabetes and hypertension | 1 (4) |
| Sample size, median (range) | 75 (14-250) | |
| Mean age of participants in years, mean (range) | 57.3 (48.4-69.5) | |
| Proportion of male participants in %, median (range) | 54 (28-76) | |
| Trial length in months, median (range) | 6 (2-12) | |